National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Amendment (No. 2) Determination 2023 (Cth)

Case
No judgment structure available for this case.

National Health (Pharmaceutical Benefits)

(Pharmacist Substitution of Medicines without

Prescription during Shortages) Amendment (No. 2) Determination 2023

I, Nikolai Tsyganov, as delegate of the Minister for Health and Aged Care, make the following determination.

Dated     13 April 2023

Nikolai Tsyganov

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health and Aged Care

Contents

1......... Name............................................................................................................................... 1

2......... Commencement............................................................................................................... 1

3......... Authority......................................................................................................................... 1

4......... Schedules......................................................................................................................... 1

Schedule 1—Amendments   1

National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021

1  Name

(1)    This instrument is the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Amendment (No. 2) Determination 2023.

(2)    This instrument may also be cited as PB 32 of 2023.

2  Commencement

(1)    Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1 Column 2 Column 3
Provisions Commencement Date/Details
1.  The whole of this instrument 17 April 2023  17 April 2023

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)    Any information in column 3 of the table is not part of this instrument.

Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under subsection 89A(3) of the National Health Act 1953.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Pharmaceutical Benefits) (Pharmacist Substitution of

Medicines without Prescription during Shortages) Determination 2021

1  Subsection 5(8), after item 30 dealing with Warfarin

Insert:

31

Listed drug: Phenoxymethylpenicillin 

Form: Powder for oral liquid 125 mg (as potassium) per 5 mL, 100 mL

Manner of administration: Oral

Brand: Phenoxymethylpenicillin-AFT

Listed drug: Phenoxymethylpenicillin 

Form: Oral suspension 150 mg (as benzathine) per 5 mL, 100 mL

Manner of administration: Oral

Brand: Cilicaine V

32

Listed drug: Phenoxymethylpenicillin 

Form: Powder for oral liquid 125 mg (as potassium) per 5 mL, 100 mL

Manner of administration: Oral

Brand: Phenoxymethylpenicillin-AFT

Listed drug: Phenoxymethylpenicillin 

Form: Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL

Manner of administration: Oral

Brand: Phenoxymethylpenicillin-AFT

33

Listed drug: Phenoxymethylpenicillin 

Form: Powder for oral liquid 125 mg (as potassium) per 5 mL, 100 mL

Manner of administration: Oral

Brand: Phenoxymethylpenicillin-AFT

Listed drug: Phenoxymethylpenicillin 

Form: Capsule 250 mg phenoxymethylpenicillin (as potassium)

Manner of administration: Oral

Brand: Any of the following:

a)    Cilicaine VK

b)   LPV

34

Listed drug: Phenoxymethylpenicillin 

Form: Powder for oral liquid 125 mg (as potassium) per 5 mL, 100 mL

Manner of administration: Oral

Brand: Phenoxymethylpenicillin-AFT

Listed drug: Phenoxymethylpenicillin 

Form: Tablet 250 mg phenoxymethylpenicillin (as potassium)

Manner of administration: Oral

Brand: Aspecillin VK

35

Listed drug: Phenoxymethylpenicillin 

Form: Oral suspension 150 mg (as benzathine) per 5 mL, 100 mL

Manner of administration: Oral

Brand: Cilicaine V

Listed drug: Phenoxymethylpenicillin

Form: Powder for oral liquid 125 mg (as potassium) per 5 mL, 100

Manner of administration: Oral

Brand:  Phenoxymethylpenicillin-AFT

36

Listed drug: Phenoxymethylpenicillin 

Form: Oral suspension 150 mg (as benzathine) per 5 mL, 100 mL

Manner of administration: Oral

Brand:   Cilicaine V

Listed drug: Phenoxymethylpenicillin 

Form: Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL

Manner of administration: Oral

Brand: Phenoxymethylpenicillin-AFT  

37

Listed drug: Phenoxymethylpenicillin 

Form: Oral suspension 150 mg (as benzathine) per 5 mL, 100 mL

Manner of administration: Oral

Brand:   Cilicaine V

Listed drug: Phenoxymethylpenicillin 

Form: Capsule 250 mg phenoxymethylpenicillin (as potassium)

Manner of administration: Oral

Brand: Any of the following:

a)    Cilicaine VK

b)    LPV

38

Listed drug: Phenoxymethylpenicillin 

Form: Oral suspension 150 mg (as benzathine) per 5 mL, 100 mL

Manner of administration: Oral

Brand:   Cilicaine V

Listed drug: Phenoxymethylpenicillin 

Form: Tablet 250 mg phenoxymethylpenicillin (as potassium)

Manner of administration: Oral

Brand:  Aspecillin VK

39

Listed drug: Phenoxymethylpenicillin 

Form: Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL

Manner of administration: Oral

Brand:  Phenoxymethylpenicillin-AFT

Listed drug: Phenoxymethylpenicillin 

Form: Powder for oral liquid 125 mg (as potassium) per 5 mL, 100 mL

Manner of administration: Oral

Brand:  Phenoxymethylpenicillin-AFT

40

Listed drug: Phenoxymethylpenicillin 

Form: Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL

Manner of administration: Oral

Brand:  Phenoxymethylpenicillin-AFT

Listed drug: Phenoxymethylpenicillin 

Form: Oral suspension 150 mg (as benzathine) per 5 mL, 100 mL

Manner of administration: Oral

Brand: Cilicaine V

41

Listed drug: Phenoxymethylpenicillin 

Form: Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL

Manner of administration:  Oral

Brand:  Phenoxymethylpenicillin-AFT

Listed drug: Phenoxymethylpenicillin 

Form: Capsule 250 mg phenoxymethylpenicillin (as potassium)

Manner of administration: Oral

Brand: Any of the following:

a)    Cilicaine VK

b)    LPV

42

Listed drug: Phenoxymethylpenicillin

Form: Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL

Manner of administration: Oral

Brand:  Phenoxymethylpenicillin-AFT

Listed drug: Phenoxymethylpenicillin 

Form: Tablet 250 mg phenoxymethylpenicillin (as potassium)

Manner of administration: Oral

Brand: Aspecillin VK

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0